Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 85.5K | 436.89K | -63.39%369.2K | |||||||
| Other cash income from operating activities | --85.5K | ---- | ---- | ---- | --436.89K | ---- | ---- | ---- | ---- | -63.39%369.2K |
| Cash paid | -73.02%-4.77M | -3.17%-2.76M | -65.25%-2.67M | -34.15%-1.62M | 25.81%-1.21M | -93.94%-1.62M | -356.71%-837.81K | 67.82%-183.44K | 79.40%-570K | 43.01%-2.77M |
| Payments to suppliers for goods and services | -73.02%-4.77M | -3.17%-2.76M | -65.25%-2.67M | -34.15%-1.62M | 25.81%-1.21M | -93.94%-1.62M | -356.71%-837.81K | 59.42%-183.44K | 74.07%-452.02K | -36.22%-1.74M |
| Other cash payments from operating activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 88.47%-117.98K | 71.37%-1.02M |
| Direct interest paid | ---18.04K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Direct interest received | 2.77%187.63K | 79.18%182.58K | 7,111.18%101.89K | 52.43%1.41K | -94.22%927 | -62.97%16.04K | 752.93%43.31K | -20.08%5.08K | -45.73%6.35K | -72.45%11.71K |
| Direct tax refund paid | ---8.03K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating cash flow | -75.69%-4.52M | -0.16%-2.57M | -59.08%-2.57M | -110.47%-1.62M | 52.28%-767.68K | -102.50%-1.61M | -345.43%-794.49K | 68.35%-178.37K | 76.38%-563.64K | 37.29%-2.39M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 83.97%-7.58M | 4.38%-47.29M | -247.99%-49.46M | -956.74%-14.21M | -66.67%-1.34M | 59.11%-806.9K | -1,603.39%-1.97M | -120.49%-115.86K | 565.34K | |
| Capital expenditure reported | 84.01%-7.56M | 2.83%-47.29M | -252.89%-48.67M | -925.40%-13.79M | -80.41%-1.34M | 31.48%-745.45K | -808.12%-1.09M | ---119.81K | ---- | ---- |
| Net PPE purchase and sale | ---9.56K | ---- | ---- | ---396.79K | ---- | -33.13%-61.45K | ---46.16K | ---- | ---- | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.30%3.95K | --565.34K | ---- |
| Net investment purchase and sale | ---5.08K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net other investing changes | ---- | ---- | -3,108.27%-790.13K | ---24.63K | ---- | ---- | ---839.39K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 83.97%-7.58M | 4.38%-47.29M | -247.99%-49.46M | -956.74%-14.21M | -66.67%-1.34M | 59.11%-806.9K | -1,603.39%-1.97M | -120.49%-115.86K | --565.34K | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -41.81%17.57M | -50.44%30.19M | 199.06%60.92M | 108.17%20.37M | 470.52%9.79M | 31,078.35%1.72M | -100.13%-5.54K | 398.59%4.2M | -56.46%842.2K | -52.98%1.93M |
| Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 366.71%1.93M |
| Net common stock issuance | -41.50%17.57M | -47.40%30.03M | 240.13%57.08M | 71.49%16.78M | 435.44%9.79M | 33,108.18%1.83M | -100.13%-5.54K | 398.59%4.2M | --842.2K | ---- |
| Net other financing activities | -98.17%3.04K | -95.69%165.66K | 7.03%3.84M | 70.95%3.59M | 1,968.46%2.1M | ---112.39K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -41.81%17.57M | -50.44%30.19M | 199.06%60.92M | 108.17%20.37M | 470.52%9.79M | 31,078.35%1.72M | -100.13%-5.54K | 398.59%4.2M | -56.46%842.2K | -52.98%1.93M |
| Net cash flow | ||||||||||
| Beginning cash position | -85.80%3.26M | 67.16%22.93M | 50.17%13.72M | 510.23%9.14M | -32.39%1.5M | -55.61%2.21M | 360.59%4.99M | 12,383.10%1.08M | -98.74%8.68K | 85.14%690.65K |
| Current changes in cash | 127.80%5.47M | -321.11%-19.67M | 95.78%8.9M | -40.78%4.54M | 1,195.48%7.67M | 74.75%-700.46K | -171.03%-2.77M | 362.72%3.9M | 286.81%843.89K | -250.03%-451.75K |
| Effect of exchange rate changes | -747.73%-47.23K | -101.76%-5.57K | 707.10%317.35K | 211.89%39.32K | -109.27%-35.14K | -49,491.18%-16.79K | --34 | ---- | 211,222.02%230.34K | -99.34%109 |
| End cash Position | 166.49%8.68M | -85.80%3.26M | 67.16%22.93M | 50.17%13.72M | 510.23%9.14M | -32.39%1.5M | -55.61%2.21M | 360.59%4.99M | 353.07%1.08M | -65.39%239.02K |
| Free cash from | 75.74%-12.1M | 2.68%-49.86M | -224.22%-51.24M | -648.05%-15.8M | 12.55%-2.11M | -25.26%-2.42M | -546.82%-1.93M | 47.10%-298.17K | 76.38%-563.64K | 37.42%-2.39M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |